申请人:Demont Hubert Emmanuel
公开号:US20060211740A1
公开(公告)日:2006-09-21
The present invention relates to novel hydroxyethylamine compounds having Asp2 (β-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease.
本发明涉及一种新型的羟乙基胺化合物,具有Asp2(β-分泌酶,BACE1或Memapsin)抑制活性,其制备过程,含有它们的组合物以及它们在治疗β-淀粉样蛋白水平或β-淀粉样蛋白沉积物增高的疾病,尤其是阿尔茨海默病中的应用。